Filtros : "Haskó, Gÿorgy" Limpar

Filtros



Refine with date range


  • Source: European Journal of Pharmacology,. Unidade: FM

    Subjects: COLITE ULCERATIVA, RECEPTORES, CITOCINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MABLEY, Jon et al. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. European Journal of Pharmacology, v. 466, p. 323-329, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0014-2999(03)01570-x. Acesso em: 23 maio 2024.
    • APA

      Mabley, J., Soriano, F., Pacher, P., Haskó, G., Marton, A., Wallace, R., et al. (2003). The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. European Journal of Pharmacology,, 466, 323-329. doi:10.1016/s0014-2999(03)01570-x
    • NLM

      Mabley J, Soriano F, Pacher P, Haskó G, Marton A, Wallace R, Salzman A, Szabó C. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis [Internet]. European Journal of Pharmacology,. 2003 ; 466 323-329.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/s0014-2999(03)01570-x
    • Vancouver

      Mabley J, Soriano F, Pacher P, Haskó G, Marton A, Wallace R, Salzman A, Szabó C. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis [Internet]. European Journal of Pharmacology,. 2003 ; 466 323-329.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/s0014-2999(03)01570-x
  • Source: American Journal of Respiratory and Critical Care Medicine. Unidade: FM

    Assunto: CIRURGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIAUDET, Lucas et al. Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. American Journal of Respiratory and Critical Care Medicine, v. 165, p. 372-377, 2002Tradução . . Acesso em: 23 maio 2024.
    • APA

      Liaudet, L., Pancher, P., Mabley, J. G., Virág, L., Soriano, F., Haskó, G., & Szabó, C. (2002). Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. American Journal of Respiratory and Critical Care Medicine, 165, 372-377.
    • NLM

      Liaudet L, Pancher P, Mabley JG, Virág L, Soriano F, Haskó G, Szabó C. Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. American Journal of Respiratory and Critical Care Medicine. 2002 ; 165 372-377.[citado 2024 maio 23 ]
    • Vancouver

      Liaudet L, Pancher P, Mabley JG, Virág L, Soriano F, Haskó G, Szabó C. Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. American Journal of Respiratory and Critical Care Medicine. 2002 ; 165 372-377.[citado 2024 maio 23 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024